Latest News

Elsalys Biotech and DKFZ collaborate to develop ELB021 in B-Cell leukaemia

Elsalys Biotech has entered a preclinical collaboration with German cancer research institute DKFZ to initiate the development of ELB021 in B-Cell leukaemia, under European Union (EU)...

Elsalys Biotech and DKFZ collaborate to develop ELB021 in B-Cell leukaemia

GSK to invest additional £140m at UK manufacturing sites

GlaxoSmithKline (GSK) is set to invest more than £140m at its production facilities in the UK to improve the efficiency and competitiveness of its manufacturing...

GSK to invest additional £140m at UK manufacturing sites

Gilead’s Vosevi receives FDA approval for re-treatment of chronic HCV

Gilead’s Vosevi receives FDA approval for re-treatment of chronic HCV

Valeant to sell Obagi medical products business for $190m

Valeant Pharmaceuticals International has entered an agreement through certain affiliates to divest its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition...

Valeant to sell Obagi medical products business for $190m

Research team discovers epithelial cells in eyes can prevent spread of Ebola

Research team discovers epithelial cells in eyes can prevent spread of Ebola

Takeda and Prana to research neurodegeneration treatment for Parkinson's disease

Takeda Pharmaceuticals International has entered a new research collaboration to study the ability of Prana Biotechnology’s investigational movement disorders compound, PBT434, to slow down...

Takeda and Prana to research neurodegeneration treatment for Parkinson's disease

FDA asks for additional data to approve Evenity in US

Pharmaceutical companies Amgen and UCB have received a Complete Response Letter from the US Food and Drug Administration (FDA) for Evenity, a treatment for postmenopausal women with...

FDA asks for additional data to approve Evenity in US

Roche’s Ocrevus receives TGA approval for RMS and PPMS treatment in Australia

Roche’s Ocrevus receives TGA approval for RMS and PPMS treatment in Australia

UDG Healthcare to acquire Cambridge BioMarketing for up to $35m

International healthcare services provider UDG Healthcare has agreed to acquire US-based healthcare communications business Cambridge BioMarketing for a total consideration of up to...

UDG Healthcare to acquire Cambridge BioMarketing for up to $35m

Janssen Biotech’s Tremfya receives FDA approval for plaque psoriasis treatment

The US Food and Drug Administration (FDA) has granted approval for Janssen Biotech’s Tremfya (guselkumab) to treat adults with moderate-to-severe plaque psoriasis who are candidates for...

Janssen Biotech’s Tremfya receives FDA approval for plaque psoriasis treatment

US FDA accepts Pfizer’s sNDA for Xeljanz to treat ulcerative colitis

US FDA accepts Pfizer’s sNDA for Xeljanz to treat ulcerative colitis

Emergent BioSolutions to buy Sanofi’s smallpox vaccine business for $125m

US-based Emergent BioSolutions has entered an agreement to buy the ACAM2000, smallpox vaccine business of French pharmaceutical company Sanofi for up to...

Emergent BioSolutions to buy Sanofi’s smallpox vaccine business for $125m

EMA validates Gilead Sciences’ marketing application for BIC/FTC/TAF combination

US biopharmaceutical company Gilead Sciences’ marketing authorisation application (MAA) for a fixed-dose drug combination to treat HIV-1 infection in adults has been fully validated and...

EMA validates Gilead Sciences’ marketing application for BIC/FTC/TAF combination

M&As this week: Sanofi, GE Healthcare, Medicure

Sanofi has announced plans to acquire US-based vaccines biotechnology company, Protein Sciences...

M&As this week: Sanofi, GE Healthcare, Medicure

Deals this week: North China Pharmaceutical, Arena Pharmaceuticals, Enterome Bioscience

Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn...

Deals this week: North China Pharmaceutical, Arena Pharmaceuticals, Enterome Bioscience

FDA recommends approval for Novartis’ CTL019 to treat r/r B-cell ALL

FDA recommends approval for Novartis’ CTL019 to treat r/r B-cell ALL

BNF and BNFC launch new app for health and social care professionals

The British National Formulary (BNF) and the British National Formulary for children (BNFC) have launched a new faster and easily accessible app for healthcare...

BNF and BNFC launch new app for health and social care professionals

New report shows decrease in app launch by pharmaceutical companies

A new report published by Research2Guidance has shown that the chances of major pharmaceutical companies to launch successful apps have decreased from 2.0% in 2014 to 0.5% in...

New report shows decrease in app launch by pharmaceutical companies

AstraZeneca to invest $100m to expand Sydney manufacturing plant

AstraZeneca to invest $100m to expand Sydney manufacturing plant

Erytech and Queen’s University collaborate for arginase-1 deficiency treatment

French biopharmaceutical company Erytech Pharma has entered a research collaboration with Queen’s University in Canada to advance the preclinical development of its eryminase...

Erytech and Queen’s University collaborate for arginase-1 deficiency treatment

Sanofi agrees to buy Protein Sciences for $750m

Sanofi has entered an agreement to acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut,...

Sanofi agrees to buy Protein Sciences for $750m
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_946450448